KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Haemophilus influenzae (gatifloxacin-susceptible)

• Haemophilus influenzae
• Haemophilus influenzae (0131)
• Haemophilus influenzae (033803 960614)
• Haemophilus influenzae (11)
• Haemophilus influenzae (233)
• Haemophilus influenzae (351HT3)
• Haemophilus influenzae (86 + β-lactamase positive)
• Haemophilus influenzae (ACH-0056 + type b)
• Haemophilus influenzae (acr)
• Haemophilus influenzae (ampicillin-resistant + ESBL)
• Haemophilus influenzae (ampicillin-resistant + β-lactamase negative)
• Haemophilus influenzae (ampicillin-resistant)
• Haemophilus influenzae (ampicillin-susceptible)
• Haemophilus influenzae (ATCC 19418)
• Haemophilus influenzae (ATCC 31517)
• Haemophilus influenzae (ATCC 35056)
• Haemophilus influenzae (ATCC 43095)
• Haemophilus influenzae (ATCC 49247)
• Haemophilus influenzae (azithromycin-susceptible)
• Haemophilus influenzae (B 0529)
• Haemophilus influenzae (ciprofloxacin-susceptible)
• Haemophilus influenzae (DILL)
• Haemophilus influenzae (ESBL + ampicillin-resistant)
• Haemophilus influenzae (ESBL + ampicillin-susceptible)
• Haemophilus influenzae (ESBL)
• Haemophilus influenzae (Europe)
• Haemophilus influenzae (gatifloxacin-susceptible)
• Haemophilus influenzae (GYR 1435)
• Haemophilus influenzae (H128)
• Haemophilus influenzae (H233)
• Haemophilus influenzae (H338)
• Haemophilus influenzae (HI-1 + ESBL)
• Haemophilus influenzae (HTM)
• Haemophilus influenzae (levofloxacin-susceptible)
• Haemophilus influenzae (LJ5)
• Haemophilus influenzae (LS-2)
• Haemophilus influenzae (LS-3)
• Haemophilus influenzae (MB4572)
• Haemophilus influenzae (MHF)
• Haemophilus influenzae (moxifloxacin-susceptible)
• Haemophilus influenzae (NCTC 11931)
• Haemophilus influenzae (Neqas 4012)
• Haemophilus influenzae (NN400)
• Haemophilus influenzae (non-ESBL + ampicillin-susceptible)
• Haemophilus influenzae (non-ESBL)
• Haemophilus influenzae (North America)
• Haemophilus influenzae (penicillin-resistant)
• Haemophilus influenzae (penicillin-susceptible)
• Haemophilus influenzae (polymyxin B-resistant)
• Haemophilus influenzae (polymyxin B-susceptible)
• Haemophilus influenzae (quinolone-resistant)
• Haemophilus influenzae (quinolone-susceptible)
• Haemophilus influenzae (RD-51907)
• Haemophilus influenzae (Spain 7)
• Haemophilus influenzae (speeding)
• Haemophilus influenzae (TH13)
• Haemophilus influenzae (tobramycin-intermediate)
• Haemophilus influenzae (tobramycin-resistant)
• Haemophilus influenzae (tobramycin-susceptible)
• Haemophilus influenzae (trimethoprim-resistant)
• Haemophilus influenzae (trimethoprim-susceptible)
• Haemophilus influenzae (TUM8)
• Haemophilus influenzae (UC30063)
• Haemophilus influenzae (VHIN6529)
• Haemophilus influenzae (β-lactamase negative)
• Haemophilus influenzae (β-lactamase positive)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8